Blood Pool Agent Offers Promise For Imaging
BR38, a new microbubble-based blood pool agent for contrast-enhanced ultrasound imaging, offers promise for non-cardiac and cardiac applications, including myocardial perfusion imaging, according to a study in the August issue of Investigative Radiology. Characterized by a long persistence and low shadowing, BR38 “shows a very good safety profile,” the authors write. No serious adverse events and no significant changes in vital signs, electrocardiographs, and laboratory tests were observed in Phase I human volunteers, they assert. To read the abstract, click here: